Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Seoul National University Hospital
Seoul National University Hospital
Washington University School of Medicine
Artiva Biotherapeutics, Inc.
Hoffmann-La Roche
Columbia University
Juno Therapeutics, a Subsidiary of Celgene
Merck Sharp & Dohme LLC
Fate Therapeutics
University of Arizona
Fate Therapeutics
Incyte Corporation
Incyte Corporation
PrECOG, LLC.
Emory University
Incyte Corporation
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Insel Gruppe AG, University Hospital Bern
Polish Lymphoma Research Group
German CLL Study Group
German CLL Study Group
German CLL Study Group
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
St. Petersburg State Pavlov Medical University
Damanhour University
University of Giessen
University of Giessen
AbbVie
Corewell Health West
M.D. Anderson Cancer Center
Seagen Inc.
Gilead Sciences
St. Petersburg State Pavlov Medical University
Wake Forest University Health Sciences
Celgene
Washington University School of Medicine
Hoffmann-La Roche
Eastern Cooperative Oncology Group
University of Wisconsin, Madison
Teva Branded Pharmaceutical Products R&D, Inc.
Brown University
International Extranodal Lymphoma Study Group (IELSG)
Hoffmann-La Roche
Hoffmann-La Roche